https://www.reedland.com/wp-content/uploads/2017/04/Oncothyroen-Corp.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-07-07 17:21:142017-04-17 17:22:18Oncothyreon Secures $20 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/durect-corp.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-07-01 17:22:272017-04-17 17:27:05DURECT Corporation Secures $50 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/celsion.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-06-17 17:27:332017-04-17 17:31:05Celsion Corporation Secures $15 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/jones-soda-company.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-06-14 17:31:482017-04-17 17:35:45Jones Soda Co. Secures $10 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/alexza-pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-05-26 17:41:582017-04-17 17:45:19Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
https://www.reedland.com/wp-content/uploads/2017/04/vical.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2010-01-10 17:45:532017-04-17 17:50:34Vical Secures $25 Million Issuer Managed Equity Facility With Azimuth Opportunity, Ltd.
https://www.reedland.com/wp-content/uploads/2017/04/map-pharmaceutical-corp.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-11-12 17:51:002017-04-17 17:57:06MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/threshold-pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-10-06 17:57:462017-04-17 18:02:56Threshold Pharmaceuticals Completes $35 Million Private Equity Financing
https://www.reedland.com/wp-content/uploads/2017/04/emcore.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-10-01 18:03:052017-04-17 18:08:03EMCORE Secures $25 Million Equity Financing Commitment
https://www.reedland.com/wp-content/uploads/2017/04/affymax-corp.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-09-25 18:08:112017-04-17 18:11:56Affymax Secures $60 Million Issuer Managed Equity Facility with Azimuth Opportunity, Ltd.
https://www.reedland.com/wp-content/uploads/2017/04/poniard-pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-08-20 18:14:302017-04-17 18:17:12Poniard Pharmaceuticals Secures $60 Million Committed Equity Financing Facility
https://www.reedland.com/wp-content/uploads/2017/04/nps-pharmaceuticals.jpg
292
560
reedland
https://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.png
reedland2009-08-06 18:17:402017-04-17 18:21:18NPS Pharmaceuticals Secures $40 Million Committed Equity Financing Facility
Scroll to top
